A critical statement came from England after 7 people with the corona virus vaccine developed by Oxford-AstraZeneca died due to blood clots.
It was announced that the trial of the Oxford-AstraZeneca vaccine on children was suspended in the country.
Professor Andrew Pollard of the University of Oxford told the British media that the team was expecting more information and that there were no safety concerns about the vaccine.
“CONNECTION OPEN” MESSAGE FROM EMA
Marco Cavaleri of the European Medicines Agency (EMA) argued that the link between the Covid-19 vaccine developed by the University of Oxford and AstraZeneca and blood clotting cases is ‘open’.
Cavaleri noted that more blood clotting cases than expected were seen among young people vaccinated with AstraZeneca’s Kovid-19 vaccine, which was developed jointly by Oxford University and a Swedish-based pharmaceutical company.
7 PEOPLE LOSE LIVES
The UK Medicines and Healthcare Products Regulatory Authority confirmed that 7 people in the country died from a blood clot after receiving the corona virus vaccine developed by Oxford and AstraZeneca.
In the statement made by the institution, it was stated that 30 of the 18 million people vaccinated had blood clot side effects and 7 of them died in the report covering the period between 9 December 2020 and 21 March 2021.